Cost-Effectiveness Analysis of Adding New Drug Thiozonide To Iv-Th Drug Regimens For Multidrug-Resistant Tuberculosis
Abstract
Authors
I Krysanov V Ermakova M Tiapkina
I Krysanov V Ermakova M Tiapkina
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now